Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine in Japanese Subjects With Perennial Allergic Rhinitis
NCT01918033Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desloratadine in perennial allergic rhinitis (PAR), sponsored by Organon & Co.. Started Aug 2013; status: completed.
02
Drugs
desloratadine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01918033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918033.